Healthcare -
Biotechnology - NASDAQ - US
$ 690.89
-1.12 %
$ 74.3 B
Market Cap
18.01
P/E
REGN - TOTAL EQUITY
Total Equity REGN - Regeneron Pharmaceuticals, Inc.
29.4 B
LAST VALUE
13.81%
2 YEAR CAGR
21.49%
5 YEAR CAGR
27.72%
10 YEAR CAGR